The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial

Monica L. Kasting, Katharine J. Head, Dena Cox, Anthony D. Cox, Gregory Zimet

Research output: Contribution to journalArticle

Abstract

Many adults in the U.S. do not receive recommended vaccines, and the research literature remains inconclusive on the best communication strategies for increasing this behavior. This study examined the association of message framing (gained-framed vs. loss-framed vs. control), and healthcare provider (HCP) recommendation (offered vs. recommended) on uptake of adult hepatitis B virus (HBV) vaccination in a high risk population using a 3 × 2 block design randomized controlled trial. Fear of shots, fear of vaccines, and perceived message framing were examined in secondary analyses. Of the 1747 participants, 47.7% (n = 833) received 0 doses of HBV vaccine, 27.8% (n = 485) received 1 dose, 10.4% received 2 doses, and 14.1% received all 3 recommended doses. There was not a significant interaction between message framing and HCP recommendation (p =.59). Mean number of doses received by the gain-framed group (m = 0.96) was not significantly different from the loss-framed group (m = 0.97, RR = 0.99, 95% CI = 0.88–1.12). However, those receiving any framing message received significantly more doses (m = 0.96) than those in the control condition (m = 0.81, RR = 1.17, 95%CI = 1.06–1.31). Participants who received a HCP recommendation received significantly more vaccine doses (m = 0.95) than those in the vaccine-offered condition (mean = 0.82, RR = 1.16, 95%CI = 1.05–1.28). These results suggest there is no difference in vaccine uptake between gain-frame and loss-frame messages, but both are better than a control message. These results also support advising HCP to provide a strong recommendation for vaccinations beyond merely offering it to patients. This study has implications for vaccine uptake beyond HBV, and can inform future research on effective vaccine communication research. Clinicaltrials.gov Identifier: NCT00739752. Registration date: August 20, 2008.

Original languageEnglish (US)
Article number105798
JournalPreventive Medicine
Volume127
DOIs
StatePublished - Oct 1 2019

Fingerprint

Patient Acceptance of Health Care
Health Communication
Hepatitis B Vaccines
Health Promotion
Hepatitis B
Hepatitis B virus
Health Personnel
Vaccination
Vaccines
Randomized Controlled Trials
Fear
Communication
Research

Keywords

  • Framing
  • Health communication
  • Health promotion
  • Hepatitis B vaccines
  • Hepatitis B virus
  • Patient acceptance of healthcare
  • Prospect theory
  • Randomized controlled trial
  • Vaccination
  • Vaccine uptake

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination : A randomized controlled trial. / Kasting, Monica L.; Head, Katharine J.; Cox, Dena; Cox, Anthony D.; Zimet, Gregory.

In: Preventive Medicine, Vol. 127, 105798, 01.10.2019.

Research output: Contribution to journalArticle

@article{514ba12425df4647b59a7c6b9191cad3,
title = "The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial",
abstract = "Many adults in the U.S. do not receive recommended vaccines, and the research literature remains inconclusive on the best communication strategies for increasing this behavior. This study examined the association of message framing (gained-framed vs. loss-framed vs. control), and healthcare provider (HCP) recommendation (offered vs. recommended) on uptake of adult hepatitis B virus (HBV) vaccination in a high risk population using a 3 × 2 block design randomized controlled trial. Fear of shots, fear of vaccines, and perceived message framing were examined in secondary analyses. Of the 1747 participants, 47.7{\%} (n = 833) received 0 doses of HBV vaccine, 27.8{\%} (n = 485) received 1 dose, 10.4{\%} received 2 doses, and 14.1{\%} received all 3 recommended doses. There was not a significant interaction between message framing and HCP recommendation (p =.59). Mean number of doses received by the gain-framed group (m = 0.96) was not significantly different from the loss-framed group (m = 0.97, RR = 0.99, 95{\%} CI = 0.88–1.12). However, those receiving any framing message received significantly more doses (m = 0.96) than those in the control condition (m = 0.81, RR = 1.17, 95{\%}CI = 1.06–1.31). Participants who received a HCP recommendation received significantly more vaccine doses (m = 0.95) than those in the vaccine-offered condition (mean = 0.82, RR = 1.16, 95{\%}CI = 1.05–1.28). These results suggest there is no difference in vaccine uptake between gain-frame and loss-frame messages, but both are better than a control message. These results also support advising HCP to provide a strong recommendation for vaccinations beyond merely offering it to patients. This study has implications for vaccine uptake beyond HBV, and can inform future research on effective vaccine communication research. Clinicaltrials.gov Identifier: NCT00739752. Registration date: August 20, 2008.",
keywords = "Framing, Health communication, Health promotion, Hepatitis B vaccines, Hepatitis B virus, Patient acceptance of healthcare, Prospect theory, Randomized controlled trial, Vaccination, Vaccine uptake",
author = "Kasting, {Monica L.} and Head, {Katharine J.} and Dena Cox and Cox, {Anthony D.} and Gregory Zimet",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.ypmed.2019.105798",
language = "English (US)",
volume = "127",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination

T2 - A randomized controlled trial

AU - Kasting, Monica L.

AU - Head, Katharine J.

AU - Cox, Dena

AU - Cox, Anthony D.

AU - Zimet, Gregory

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Many adults in the U.S. do not receive recommended vaccines, and the research literature remains inconclusive on the best communication strategies for increasing this behavior. This study examined the association of message framing (gained-framed vs. loss-framed vs. control), and healthcare provider (HCP) recommendation (offered vs. recommended) on uptake of adult hepatitis B virus (HBV) vaccination in a high risk population using a 3 × 2 block design randomized controlled trial. Fear of shots, fear of vaccines, and perceived message framing were examined in secondary analyses. Of the 1747 participants, 47.7% (n = 833) received 0 doses of HBV vaccine, 27.8% (n = 485) received 1 dose, 10.4% received 2 doses, and 14.1% received all 3 recommended doses. There was not a significant interaction between message framing and HCP recommendation (p =.59). Mean number of doses received by the gain-framed group (m = 0.96) was not significantly different from the loss-framed group (m = 0.97, RR = 0.99, 95% CI = 0.88–1.12). However, those receiving any framing message received significantly more doses (m = 0.96) than those in the control condition (m = 0.81, RR = 1.17, 95%CI = 1.06–1.31). Participants who received a HCP recommendation received significantly more vaccine doses (m = 0.95) than those in the vaccine-offered condition (mean = 0.82, RR = 1.16, 95%CI = 1.05–1.28). These results suggest there is no difference in vaccine uptake between gain-frame and loss-frame messages, but both are better than a control message. These results also support advising HCP to provide a strong recommendation for vaccinations beyond merely offering it to patients. This study has implications for vaccine uptake beyond HBV, and can inform future research on effective vaccine communication research. Clinicaltrials.gov Identifier: NCT00739752. Registration date: August 20, 2008.

AB - Many adults in the U.S. do not receive recommended vaccines, and the research literature remains inconclusive on the best communication strategies for increasing this behavior. This study examined the association of message framing (gained-framed vs. loss-framed vs. control), and healthcare provider (HCP) recommendation (offered vs. recommended) on uptake of adult hepatitis B virus (HBV) vaccination in a high risk population using a 3 × 2 block design randomized controlled trial. Fear of shots, fear of vaccines, and perceived message framing were examined in secondary analyses. Of the 1747 participants, 47.7% (n = 833) received 0 doses of HBV vaccine, 27.8% (n = 485) received 1 dose, 10.4% received 2 doses, and 14.1% received all 3 recommended doses. There was not a significant interaction between message framing and HCP recommendation (p =.59). Mean number of doses received by the gain-framed group (m = 0.96) was not significantly different from the loss-framed group (m = 0.97, RR = 0.99, 95% CI = 0.88–1.12). However, those receiving any framing message received significantly more doses (m = 0.96) than those in the control condition (m = 0.81, RR = 1.17, 95%CI = 1.06–1.31). Participants who received a HCP recommendation received significantly more vaccine doses (m = 0.95) than those in the vaccine-offered condition (mean = 0.82, RR = 1.16, 95%CI = 1.05–1.28). These results suggest there is no difference in vaccine uptake between gain-frame and loss-frame messages, but both are better than a control message. These results also support advising HCP to provide a strong recommendation for vaccinations beyond merely offering it to patients. This study has implications for vaccine uptake beyond HBV, and can inform future research on effective vaccine communication research. Clinicaltrials.gov Identifier: NCT00739752. Registration date: August 20, 2008.

KW - Framing

KW - Health communication

KW - Health promotion

KW - Hepatitis B vaccines

KW - Hepatitis B virus

KW - Patient acceptance of healthcare

KW - Prospect theory

KW - Randomized controlled trial

KW - Vaccination

KW - Vaccine uptake

UR - http://www.scopus.com/inward/record.url?scp=85070890774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070890774&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2019.105798

DO - 10.1016/j.ypmed.2019.105798

M3 - Article

AN - SCOPUS:85070890774

VL - 127

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

M1 - 105798

ER -